Commercialization

The products reached the market.

The material became a product, the product got retail packaging, and the product sold through a national distributor channel at margins that work. Sales are small. They show demand and unit economics; the scale-up is what a partner brings.

The products

From rolled goods to retail.

Aclara mask product photography — Fig. 1. Aclara finished-mask product photography.

Litespun retail mask worn in daily use, Shop Vida product photography — Fig. 3. Litespun retail line, Shop Vida product photography.

Distribution

Where it has been marketed.

Aclara masks reached consumers through the Shop Vida platform, a national print-on-demand and e-commerce distributor, under two retail product lines: Aclarawell, launched in 2023, and Litespun, launched in 2025. Distributor sales grew several-fold year over year, on organic demand alone.

Two channel structures are proven: consumer retail through the distributor's storefront, and bulk supply to organizations. Each has its own margin profile.

Consumer channel

Retail product line via Shop Vida storefront, with packaged goods and branded presentation

Bulk channel

Organizational and wholesale supply of finished masks

Consumer margins

≈4× at retail through the consumer channel

Bulk margins

2–3× at organizational volume

Fig. 5. The Aclarawell retail mark, used on the Shop Vida product line.

Aclara retail five-pack promotional photo — Fig. 6. Retail five-pack, Shop Vida promotional photography.

Aclara mask promotional photography — Fig. 7. Shop Vida promotional photography.

Aclara product in its retail presentation — Fig. 8. Aclara product in retail presentation.

Aclara retail packaging — Fig. 9. Retail packaging for the product line.

Customers paid for these products at margins that work, on organic demand. A partner inherits a tested product line, the packaging, a working distributor relationship, and market-tested pricing. FDA clearance would open the hospital and government procurement channels.